Health Condition 1: K703- Alcoholic cirrhosis of liver Health Condition 2: K74- Fibrosis and cirrhosis of liver
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients with Liver Cirrhosis Sarcopenia
Exclusion criteria
Exclusion criteria: Patients with hepatic encephalopathy (grade= II according to the WestHaven Grading System). Uncontrolled esophageal varices bleeding. Refractory ascites. Malignancy. Patients with HPS or Portopulmonary Syndrome Severe renal dysfunction (estimated glomerular filtration rate Severe cardiac disease, history of gastrectomy. Patients with Neurological Disorders Previous poor compliance with pharmacologic treatment or nutritional counseling before initiating the trial supplement. Patients with a history of hepatocellular carcinoma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate the Change in Muscle MassTimepoint: 0,1,3 & 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in albumin level, anthropometry parameters (mid arm circumference, triceps skin fold thickness, hand grip) Improvement in CTP & MELD score. Hospital admission MortalityTimepoint: 0,1,3 & 6 months | — |
Countries
India
Contacts
Sawai Man Singh Medical College